Mikel Berdud : Citation Profile


Are you Mikel Berdud?

Office of Health Economics

2

H index

0

i10 index

8

Citations

RESEARCH PRODUCTION:

2

Articles

11

Papers

RESEARCH ACTIVITY:

   6 years (2012 - 2018). See details.
   Cites by year: 1
   Journals where Mikel Berdud has often published
   Relations with other researchers
   Recent citing documents: 7.    Total self citations: 1 (11.11 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pbe1130
   Updated: 2019-12-07    RAS profile: 2018-12-20    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Towse, Adrian (4)

Hampson, Grace (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Mikel Berdud.

Is cited by:

Garau, Martina (1)

Husereau, Don (1)

Neri, Margherita (1)

Lorgelly, Paula (1)

Cites to:

Tirole, Jean (16)

Jewitt, Ian (12)

Dewatripont, Mathias (12)

Ghatak, Maitreesh (6)

Gromb, Denis (4)

Mueller, Hannes (4)

Jegen, Reto (3)

Frey, Bruno (3)

Delfgaauw, Josse (3)

Dur, Robert (3)

Hwang, Sung-Ha (3)

Main data


Where Mikel Berdud has published?


Working Papers Series with more than one paper published# docs
Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra / Departamento de Economía - Universidad Pública de Navarra6
Research Papers / Office of Health Economics3
Consulting Reports / Office of Health Economics2

Recent works citing Mikel Berdud (2018 and 2017)


YearTitle of citing document
2019Competition between on-patent medicines in Europe. (2019). Wilsdon, Tim ; Roediger, Alexander ; Azais, Boris ; Pendleton, Kathy ; Haderi, Artes. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:7:p:652-660.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. (2018). Neri, Margherita ; Garau, Martina ; Towse, A. In: Briefings. RePEc:ohe:briefg:002084.

Full description at Econpapers || Download paper

2017How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. (2017). Vogler, Sabine ; Dedet, Guillaume ; Pedersen, Hanne Bak ; Schneider, Peter ; Joncheere, Kees ; Wirtz, Veronika J ; Ferrario, Alessandra ; Paris, Valerie . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0300-z.

Full description at Econpapers || Download paper

2018Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching. (2018). Husereau, Don ; Selya-Hammer, Carl ; Feagan, Brian. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:3:d:10.1007_s40258-018-0371-0.

Full description at Econpapers || Download paper

2018Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates. (2018). Espin, Jaime ; Jommi, Claudio ; Parnaby, Adam ; Flostrand, Steven ; Hutchings, Adam ; Borget, Isabelle ; Mestre-Ferrandiz, Jorge ; Anderson, Pippa ; Godman, Brian ; Schlander, Michael. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:6:d:10.1007_s40258-018-0419-1.

Full description at Econpapers || Download paper

2017Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis. (2017). Simoens, Steven ; Shane, Lesley G ; Isakov, Leah ; Popovian, Robert ; Jacobs, Ira. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0529-x.

Full description at Econpapers || Download paper

2018The Impact of Brexit on Pharmaceuticals and HTA. (2018). Lorgelly, Paula. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-018-0072-5.

Full description at Econpapers || Download paper

Works by Mikel Berdud:


YearTitleTypeCited
2012Incentives Beyond the Money and Motivational Capital in Health Care Organizations. In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2012Motivational Capital and Incentives in Health Care Organisations. In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2014Motivational Capital and Incentives in Health Care Organizations.(2014) In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2014Motivational Capital and Incentives in Health Care Organizations.(2014) In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2012Incentives Beyond the Money: Identity and Motivational Capital in Public Organizations In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2014A Pilot Inquiry on Incentives and Intrinsic Motivation in Health Care: the Motivational Capital Explained by Doctors In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2017Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market In: Consulting Reports.
[Full Text][Citation analysis]
paper1
2018Review of CRAs Report Assessing the Economic Impacts of Changing Exemption Provisions During Patent and SPC Protection in Europe In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2017Macro Evaluation of the NIHR Oxford Biomedical Research Centre In: Research Papers.
[Full Text][Citation analysis]
paper0
2018Establishing a Reasonable Price for an Orphan Drug In: Research Papers.
[Full Text][Citation analysis]
paper0
2018R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C In: Research Papers.
[Full Text][Citation analysis]
paper2
2016Fostering incentives for research, development, and delivery of interventions for neglected tropical diseases: lessons from malaria In: Oxford Review of Economic Policy.
[Full Text][Citation analysis]
article0
2016Biosimilars: How Can Payers Get Long-Term Savings? In: PharmacoEconomics.
[Full Text][Citation analysis]
article5

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 2nd 2019. Contact: CitEc Team